The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
External validation of a MMAI model for prognosis and chemotherapy benefit prediction in postmenopausal, node-positive, hormone receptor–positive breast cancer patients: Analysis of SWOG S8814.
 
Corey Speers
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - Compositions and Methods for the Analysis of Radiosensitivity, UM-33550/US-1, Coinventor, Submitted on 09/2013; Methods and Genomic Classifiers for Prognosis of Breast Cancer and Predicting Benefit from Adjuvant Radiotherapy, Application No. 61/205,279, Co-inventor, Submitted on
 
Alexander Piehler
Employment - Artera
Stock and Other Ownership Interests - Artera
 
Allison Meisner
Research Funding - AstraZeneca
 
Jingbin Zhang
Employment - Artera
Stock and Other Ownership Interests - Artera
 
William Barlow
No Relationships to Disclose
 
Wouter Zwerink
Employment - ARTERA AI
Stock and Other Ownership Interests - Artera AI
 
Lajos Pusztai
Stock and Other Ownership Interests - Ataraxis
Honoraria - Agendia; AstraZeneca; Bristol-Myers Squibb; Merck @ Co; natera; Radionetics
Consulting or Advisory Role - Agendia; AstraZeneca; Bristol Myers Squibb; Merck; Natera; Personalis; Radionetics
Research Funding - Agendia (Inst); AstraZeneca (Inst); Bristol Myers Squibb (Inst); Exact Sciences (Inst); Menarini (Inst); Merck (Inst); Natera (Inst); Personalis (Inst); Pfizer (Inst)
(OPTIONAL) Uncompensated Relationships - Caris Life Sciences; Foundation Medicine
 
Priyanka Sharma
Stock and Other Ownership Interests - Amgen; Gilead Sciences (I); Johnson & Johnson/Janssen; Pfizer (I); Roche/Genentech (I); Sanofi
Consulting or Advisory Role - AstraZeneca; Boston Scientific (I); Cipla (I); Gilead Sciences; GlaxoSmithKline; Lilly; Merck; Novartis; Pfizer; Salient Pharmaceuticals (I); Sanofi; Stemline Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); Merck (Inst); Novartis (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
 
Calvin Chao
Employment - Artera; Exact Sciences; Tempus
Leadership - Artera; Exact Sciences; Tempus
Stock and Other Ownership Interests - Artera; Exact Sciences; Tempus
 
Alastair Thompson
Employment - Lilly (I)
Stock and Other Ownership Interests - Lilly (I)
 
Andrew Godwin
Employment - University of Kansas Health System
Stock and Other Ownership Interests - Exokeryx
Honoraria - Sinochips Diagnostics
Research Funding - Predicine (Inst); VITRAC Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Provisional - US Patent number 63/391,657 entitled “Extracellular Vesicle Proteomic Biomarker Panel for Ovarian Cancer Screening and the Early Detection of Disease”. (Inst); Provisional - US Patent number 63/496,270 entitled “Treatment of Neoplasm by Inhibiting KIF15”. (Inst); Provisional Patent application entitled - "WJMSC-Derived Small Extracellular Vesicle (sEVs) Enhance T Cell Suppression Through Checkpoint PD-L1" - Dr. Joseph McGuirk (applicant) (Inst)
 
Kathy Albain
Research Funding - Quantum Leap Healthcare Collaborative (Inst)
Other Relationship - Seagen
 
Jacqueline Griffin
Employment - Artera
Stock and Other Ownership Interests - Artera
 
James Rae
Employment - Advarra (I)
Stock and Other Ownership Interests - Advarra (I)